Ovarian cancer is the 6th most common cancer in women in the UK, with 7,400 people diagnosed each year. The symptoms of ovarian cancer can be very vague, particularly when the disease is in its early stages.
Recent research has reinforced the need for all women with ovarian cancer to receive genetic testing, but they aren’t. We explore why.
We look at the long-awaited results from a study testing whether an ovarian cancer screening programme could actually save lives from the disease.
Yesterday saw some bold, but extremely misleading headlines about hormone replacement therapy (HRT) being “harmless”. This unfortunate statement flies in…
In the latest in Our Milestones series, we look at how Cancer Research UK scientists helped develop one of the world’s most successful cancer drugs.
We explore new data showing that cancer survival in England remains lower than countries with similar healthcare systems.
It’s taken years of frustration and dedication (not to mention countless hours spent in a small room roughly the temperature…
How our researchers in Manchester are helping develop ways to make chemotherapy kinder and more effective.
In light of a preliminary ‘no’ from NICE over olaparib for ovarian cancer, we hear from one of our experts whose work led to the drug’s development
We look at headlines about a new blood test for ovarian cancer, and why a possible routine screening test for the disease is still some way off.